Catalyst Wire Dossier Catalyst Wire Dossier

Verteporfin

verteporfin · Novartis
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Verteporfin, covering 2008-01-09 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

See pricing